The biomarker, called ‘brain-derived tau,’ or BD-tau, outperforms current blood diagnostic tests used to detect Alzheimer’s-related neurodegeneration clinically. It is specific to Alzheimer’s disease and correlates well with Alzheimer’s neurodegeneration biomarkers in the cerebrospinal fluid. Scientists hope that monitoring blood levels of BD-tau could facilitate screening and enrollment of patients from populations that historically haven’t been included in research cohorts.
Click here for original story, New biomarker test can detect Alzheimer’s neurodegeneration in blood
Source: ScienceDaily